The identification of efficient radiochemical methods has been a long-standing challenge in the development and production of positron emission tomography (PET) tracers. Carbon-11, being a short-lived (t 1/2 = 20.4 min) isotope, offers a unique set of challenges for regulatory-compliant radiochemistry with exceptional time constraints. Simultaneously, the diversity of radiochemical scaffolds available from carbon-11 maintains its importance in clinical PET radiosynthesis. [ 11 C]Hydrogen cyanide ([ 11 C]HCN) represents a unique example of a versatile 11 C-synthon that can deliver broad chemical diversity for the synthesis of 11 C-labeled PET radiopharmaceuticals. This review article describes recent investigations with [ 11 C]HCN including its production, radiochemistry, and use in developing new PET radiopharmaceuticals.
No takes yet. Share an insight, caveat, or question.
McCarthy et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: